通冠胶囊对冠心病冠脉介入术患者P波离散度及QT间期离散度的影响  

Influence of Tongguan Capsule on P Wave Dispersion and QT Dispersion of Patients with CoronaryHeart Disease Treated by Percutaneous Coronary Intervention

作　　者：曹爱琴[1] 杨广[1] 张敏州[1] 

机构地区：[1]广东省中医院心内科,广东广州510120

出　　处：《中国中医药信息杂志》2007年第11期9-10,共2页Chinese Journal of Information on Traditional Chinese Medicine

摘　　要：目的通过分析通冠胶囊对冠心病冠脉介入术(PCI)患者治疗前后P波离散度(Pd)及QT间期离散度(QTd)的变化,从电生理方面评价通冠胶囊改善心肌缺血的作用。方法选择60例冠心病PCI术患者,随机分成治疗组、对照组,对照组给予常规西医治疗,治疗组在常规西医治疗基础上口服通冠胶囊,疗程4周。治疗前后测量2组患者的Pd及QTd/QTcd。结果治疗组患者的Pd及QTd/QTcd在治疗后明显下降,与对照组比较有显著差异。结论通冠胶囊能改善冠心病PCI术患者的心肌缺血。Objective To analyze P wave dispersion （Pd） and QT dispersion （QTd） of the patients with cononary heart disease （CHD） before and after percutaneous coronary intervention （PCI） and to evaluate the influence of Tongguan capsule on improving myocardial ischemia in vivo cardiac electrophysiology. Methods 60 CHD patients treated by PCI were divided into the trial group （Tongguan Capsule 4 weeks＋ conventional western medicine） and control group （conventional western medicine） randomly. Pd and QTd/QTcd of two groups before and after treamtment were measured. Results Pd and QTd/QTcd of the trial group were obviously declined. The difference between two groups was marked. Conclusion The treatment of Tongguan Capsule can improve Pd and QTd/QTcd of the patients with CHD, which suggest Tongguan Capsule can improve myocardial ischemia.

关 键 词：通冠胶囊 P波离散度 QT间期离散度 冠心病 

分 类 号：R259.414[医药卫生—中西医结合]